IP Library › Granted Patent US 8,512,940
Granted Patent B2
US 8,512,940 · App. 13/222,407 · Granted Aug 20, 2013

Method for preserving liver in a solution comprising dibutyryl cAMP

Inventors: Takaaki Koshiba (Kyoto, JP); Xiangdong Zhao (Kyoto, JP); Hiromi Wada (Kyoto, JP); Takayuki Nakamura (Kyoto, JP); Koichi Tanaka (Kyoto, JP)
Assignee: Otsuka Pharmaceutical Factory, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,940
App. No.
13/222,407
Granted
Aug 20, 2013
Kind
B2
Abstract

The present invention provides a liver preservation solution containing trehalose and dibutyryl-cAMP. The content of nitroglycerin in the preservation solution is preferably lower than 0.44 mM. In the liver preservation solution of the present invention, since the toxicity due to nitroglycerin, which is observed during liver preservation, has been improved, liver transplantation can be performed with a high engrafted rate.

Claims (25)

1. A method of preserving liver, which comprises preserving an isolated liver in a tissue preservation solution comprising at least the following components within the following ranges and having a nitroglycerin content of not more than 0.0044 mM:

dibutyryl cAMP

1.5-3

mM

trehalose

110-130

mM

hydroxyethylstarch

25-35

g/l

Na +

90-110

mM

K +

40-50

mM

H 2 PO 4 − or HPO 4 −−

20-30

mM

at least one kind selected from

90-110

mM.

Cl − , HCO 3 − , CO 3 −− , organic acid and

organic acid anion

2. The method of claim 1 , wherein the tissue preservation solution is substantially free of nitroglycerin.

Priority Claims (1)
JP 2005-299314 · Oct 13, 2005 · national
Continuity (2)
Continuation 12083503
Related Publication 20110311959A1 · Dec 22, 2011